Advances in nanomaterials for enhancing cGAS-STING pathway mediated anti-tumor treatment
Source abstract
Abstract
The cGAS-STING pathway is a crucial component of innate immunity, playing a dual role in tumor biology by promoting pro-inflammatory responses and anti-tumor immunity. Nanomaterials have emerged as transformative tools to enhance the activation and therapeutic efficacy of this pathway in cancer immunotherapy. This review targets recent advancements in nanomaterials of enhancing cGAS-STING-mediated anti-tumor immune responses. These nanomaterials leverage their unique physical and chemical properties for targeted delivery, controlled release, and biodegradability, significantly improving the anti-tumor effects through synergistic activation of the cGAS-STING pathway. This review underscores the potential of nanomaterial-based cGAS-STING therapeutics for cancer treatment and identifies key research priorities to address existing limitations and propel the field forward.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: interferon and immune responses · Viral Infections and Vectors · Herpesvirus Infections and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Harnessing innate immunity in cancer therapy10.1038/s41586-019-1593-5 ↗
2. Extrachromosomal telomere repeat DNA is linked to ALT development via cGAS-STING DNA sensing pathway10.1038/nsmb.3498 ↗
3. DNA damage and the balance between survival and death in cancer biology10.1038/nrc.2015.2 ↗
4. Oncogenic extrachromosomal DNA functions as mobile enhancers to globally amplify chromosomal transcription10.1016/j.ccell.2021.03.006 ↗
5. Ancient origin of cGAS-STING reveals mechanism of universal 2',3' cGAMP signaling10.1016/j.molcel.2015.07.022 ↗
6. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING10.1016/j.molcel.2013.05.022 ↗
7. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway10.1126/science.1232458 ↗
8. The cytoplasmic DNA sensor cGAS promotes mitotic cell death10.1016/j.cell.2019.05.035 ↗
9. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway10.1038/s41586-019-1006-9 ↗
10. FBXO38 deficiency promotes lysosome-dependent STING degradation and inhibits cGAS-STING pathway activation10.1016/j.neo.2024.100973 ↗
11. Effector memory T cells induce innate inflammation by triggering DNA damage and a non-canonical STING pathway in dendritic cells10.1016/j.celrep.2023.113180 ↗
12. A non-canonical cGAS-STING-PERK pathway facilitates the translational program critical for senescence and organ fibrosis10.1038/s41556-022-00894-z ↗
13. Structures, functions and adaptations of the human LINE-1 ORF2 protein10.1038/s41586-023-06947-z ↗
14. Targeting innate immune checkpoint TREX1 is a safe and effective immunotherapeutic strategy in cancer10.1158/0008-5472.CAN-24-2747 ↗
15. PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion10.1084/jem.20240902 ↗
16. ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion10.1038/s41556-025-01627-8 ↗
17. Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced/metastatic solid tumors or lymphomas10.1158/1078-0432.CCR-21-1963 ↗
18. Abstract A052: development of PD-L1 and STING-targeted nanoparticles for lung cancer treatment10.1158/2326-6074.IO2025-A052 ↗
19. Systemic delivery of a STING agonist-loaded positively charged liposome selectively targets tumor immune microenvironment and suppresses tumor angiogenesis
20. M335, a novel small-molecule STING agonist activates the immune response and exerts antitumor effects10.1016/j.ejmech.2023.116018 ↗
21. E7766, a macrocycle-bridged stimulator of interferon genes (STING) agonist with potent pan-genotypic activity
22. Reprogramming the tolerogenic immune response against pancreatic cancer metastases by lipid nanoparticles delivering a STING agonist plus mutant KRAS mRNA10.1021/acsnano.4c14102 ↗
23. Targeted delivery of STING agonist via albumin nanoreactor boosts immunotherapeutic efficacy against aggressive cancers10.3390/pharmaceutics16091216 ↗
24. Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy10.1016/j.biomaterials.2022.121856 ↗
25. Manganese-based immunostimulatory metal–organic framework activates the cGAS-STING pathway for cancer metalloimmunotherapy10.1021/acsnano.3c03962 ↗
26. Heterodimers of metal nanoparticles: synthesis, properties, and biological applications10.1007/s00604-021-05002-w ↗
27. Multiplex evaluation of biointerface-targeting abilities and affinity of synthetized Nanoparticles-A step towards improved nanoplatforms for biomedical applications10.3390/molecules29225270 ↗
28. A simple SERS sensor based on antibody-modified Fe3O4@Au MNPs for the detection of CA19-9 in CRC patients
29. Mitigating metal-organic framework (MOF) toxicity for biomedical applications
30. Electrophysiology of the sodium-potassium-ATPase in cardiac cells10.1152/physrev.2001.81.4.1791 ↗
31. STING modulates iron metabolism to promote liver injury and inflammation in acute immune hepatitis10.1016/j.freeradbiomed.2023.11.038 ↗
32. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy10.1016/j.scib.2023.02.027 ↗
33. A bimetallic polymerization network for effective increase in labile iron pool and robust activation of cGAS/STING induces ferroptosis-based tumor immunotherapy10.1002/smll.202308397 ↗
34. The biological effects and possible modes of action of nanosilver
35. Silver molybdate nanoparticles for enhanced tumor immunotherapy through pyroptosis conversion and ferroptosis induction10.1002/anie.202501530 ↗
36. The Ca2+ sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum10.1038/s41590-018-0287-8 ↗
37. Elevated expression of Piezo1 activates the cGAS-STING pathway in chondrocytes by releasing mitochondrial DNA10.1016/j.joca.2025.02.778 ↗
38. DNA-induced liquid phase condensation of cGAS activates innate immune signaling10.1126/science.aat1022 ↗
39. Human cGAS catalytic domain has an additional DNA-binding interface that enhances enzymatic activity and liquid-phase condensation10.1073/pnas.1905013116 ↗
40. Metal-Phenolic vehicles potentiate cycle-cascade activation of pyroptosis and cGAS-STING pathway for tumor immunotherapy10.1021/acsnano.4c08613 ↗
41. Manganese-based immunostimulatory metal-organic framework activates the cGAS-STING pathway for cancer metalloimmunotherapy10.1021/acsnano.3c03962 ↗
42. In situ non-canonical activation and sensitization of cGAS-STING pathway with manganese telluride nanosheets10.1016/j.biomaterials.2025.123170 ↗
43. Manganese@Albumin nanocomplex and its assembled nanowire activate TLR4-Dependent signaling cascades of macrophages10.1002/adma.202310979 ↗
44. Targeting STING activation by antigen-inspired MnO2 nanovaccines optimizes tumor radiotherapy10.1002/adhm.202300028 ↗
45. Enhanced tumor immunotherapy by triple amplification effects of nanomedicine on the STING signaling pathway in dendritic cells
46. Manganese molybdate nanodots with dual amplification of STING activation for "cycle" treatment of metalloimmunotherapy
47. Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system10.1007/s13346-022-01197-4 ↗
48. Assembly of 2′,3′-Cyclic guanosine monophosphate-adenosine monophosphate and their spontaneous intracellular disassembly for enhanced antitumor immunity via natural STING pathway activation10.1016/j.cej.2024.157037 ↗
49. Immunogenic cell death augmented by manganese zinc sulfide nanoparticles for metastatic melanoma immunotherapy10.1021/acsnano.2c08013 ↗
50. Poly ethylene glycol (PEG)-based hydrogels for drug delivery in cancer therapy: a comprehensive review
51. Cancer cell membrane-enveloped dexamethasone normalizes the tumor microenvironment and enhances gynecologic cancer chemotherapy10.1021/acsnano.3c03013 ↗
52. Intelligent design of polymersomes for antibacterial and anticancer applications10.1002/wnan.1822 ↗
53. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy10.1038/s41565-018-0342-5 ↗
54. A type I photosensitizer-polymersome boosts reactive oxygen species generation by forcing H-Aggregation for amplifying STING immunotherapy10.1021/jacs.4c09831 ↗
55. A polymer nanogel-based therapeutic nanovaccine for prophylaxis and direct treatment of tumors via a full-cycle immunomodulation
56. Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids10.1038/s41587-025-02556-5 ↗
57. Intravenous delivery of STING agonists using acid-sensitive polycationic polymer-modified lipid nanoparticles for enhanced tumor immunotherapy10.1016/j.apsb.2024.06.004 ↗
58. The 60-year evolution of lipid nanoparticles for nucleic acid delivery10.1038/s41573-024-00977-6 ↗
59. STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity10.1038/s41563-022-01251-z ↗
60. Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy
61. Dual-responsive nanomedicine activates programmed antitumor immunity through targeting lymphatic system10.1021/acsnano.3c11464 ↗
62. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy10.1016/j.nano.2017.10.013 ↗
63. Tumor microenvironment-responsive delivery nanosystems reverse immunosuppression for enhanced CO gas/immunotherapy
64. Peptide nanotube loaded with a STING agonist, c-di-GMP, enhance cancer immunotherapy against melanoma10.1007/s12274-022-5102-z ↗
65. Robust and sustained STING pathway activation via hydrogel-based in situ vaccination for cancer immunotherapy10.1021/acsnano.3c12337 ↗
66. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy10.1038/s41422-020-00395-4 ↗
67. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses10.1016/j.immuni.2018.03.017 ↗
68. Smart responsive Fe/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation10.1186/s12951-024-02354-2 ↗
69. He · Metal‐Phenolic Nanocloaks on Cancer Cells Potentiate STING Pathway Activation for Synergistic Cancer Immunotherapy · 2024
70. Programmed initiation and enhancement of cGAS/STING pathway for tumour immunotherapy via tailor-designed ZnFe(2)O(4)-based nanosystem
71. Ultra-small Janus nanoparticle-induced activation of ferroptosis for synergistic tumor immunotherapy10.1016/j.actbio.2024.04.032 ↗
72. Triple tumor microenvironment‐responsive ferroptosis pathways induced by manganese‐based imageable nanoenzymes for enhanced breast cancer theranostics
73. Ca & Mn dual-ion hybrid nanostimulator boosting anti-tumor immunity via ferroptosis and innate immunity awakening
74. RGD targeted magnetic ferrite nanoparticles enhance antitumor immunotherapeutic efficacy by activating STING signaling pathway10.1016/j.isci.2024.109062 ↗
75. Nanodrug augmenting antitumor immunity for enhanced TNBC therapy via pyroptosis and cGAS-STING activation10.1021/acs.nanolett.3c01008 ↗
76. Biomineralized manganese oxide nanoparticles synergistically relieve tumor hypoxia and activate immune response with radiotherapy in non-small cell lung cancer10.3390/nano12183138 ↗
77. Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction10.1186/s12951-024-02502-8 ↗
78. Biomineralized MnO 2 nanoplatforms mediated delivery of immune checkpoint inhibitors with STING pathway activation to potentiate cancer radio-immunotherapy10.1021/acsnano.2c10352 ↗
79. A hybrid nanoadjuvant simultaneously depresses PD-L1/TGF-β1 and activates cGAS-STING pathway to overcome radio-immunotherapy resistance10.1002/adma.202304328 ↗
80. Bacterially mediated drug delivery and therapeutics: strategies and advancements10.1016/j.addr.2022.114363 ↗
81. Repolarizing neutrophils via MnO2 nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy10.1186/s12951-024-02726-8 ↗
82. ATP‐Responsive manganese‐based bacterial materials synergistically activate the cGAS‐STING pathway for tumor immunotherapy10.1002/adma.202310189 ↗
83. Oxidation-responsive PolyMOF nanoparticles for combination photodynamic-immunotherapy with enhanced STING activation10.1021/acsnano.3c01333 ↗
84. Chen · 2023
85. Integrated manganese (III)-doped nanosystem for optimizing photothermal ablation: amplifying hyperthermia-induced STING pathway and enhancing antitumor immunity10.1016/j.actbio.2022.11.019 ↗
86. Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation10.1038/s41467-023-38601-7 ↗
87. Transforming cold tumors into hot ones with a metal-organic framework-based biomimetic nanosystem for enhanced immunotherapy10.1021/acsami.2c21005 ↗
88. Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells10.1002/smll.201201129 ↗
89. Polymeric curcumin nanoparticles by a facile in situ method for macrophage targeted delivery10.1002/btm2.10112 ↗
90. Size, shape, and protein Corona determine cellular uptake and removal mechanisms of gold nanoparticles10.1002/smll.201801451 ↗
91. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics10.1016/j.colsurfb.2020.110880 ↗
92. Probing the effect of rigidity on the cellular uptake of core-shell nanoparticles: stiffness effects are size dependent10.1002/smll.202203070 ↗
93. Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles10.2147/IJN.S214008 ↗
94. Tailored drug delivery platforms: stimulus-responsive core-shell structured nanocarriers10.1002/adhm.202301726 ↗
95. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer10.1016/j.ejps.2016.06.020 ↗
96. Immunity-modulating metal-based nanomaterials for cancer immunotherapy
97. Degradable polymeric bio(nano)materials and their biomedical applications: a comprehensive overview and recent updates10.3390/polym16020206 ↗
98. Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles10.1038/s41467-021-26052-x ↗
99. Oxygen-deficient molybdenum oxide nanosensitizers for ultrasound-enhanced cancer metalloimmunotherapy10.1002/anie.202215467 ↗
100. Bioorthogonal guided activation of cGAS-STING by AIE photosensitizer nanoparticles for targeted tumor therapy and imaging10.1002/adma.202305668 ↗